论文部分内容阅读
Exenatide is the first approved glucagon-like peptide 1 receptor agonist subcutaneously or intramuscularly injected for the treatment of type 2 diabetes mellitus.Typical therapeutic plasma concentrations are in the low pg/mL range,therefore requiring ultr